Industry · Public and Social
Life Sciences
Market access, local manufacturing and commercial models.
Who we serve
Pharmaceutical and biopharma companies, medical device makers, generics producers and CROs (contract research organisations). Governments want local production and lower prices, and launches still need to earn a return.
Sectors
- Pharmaceuticals and biopharma
- Medical devices and technology
- Generics
- CROs (contract research organisations)
The agenda
What leadership teams are dealing with.
Market access
Pricing, reimbursement dossiers, tenders and launch sequencing across markets with very different payers.
Local manufacturing
Business cases, partner selection and technology transfer for in-region production.
Commercial model
Field force size, key account management and digital engagement with clinicians and pharmacists.
Clinical trials
Site networks, regulatory timelines and research partnerships that bring trials into the region.
How we help
Where clients usually start.
Every service and capability is available to clients in Life Sciences. These four are where conversations usually begin.
Brand, Marketing and Sales
Commercial growth you can measure.
12 capabilitiesStrategy and Corporate Finance
Choosing where to grow, and paying for it.
11 capabilitiesOperations
Lower operating cost and better service.
9 capabilitiesMergers, Acquisitions and Transactions
Buying, selling and integrating businesses.
8 capabilitiesRelated industries
Also in Public and Social.
Working on a decision in Life Sciences?
Tell us what you are working on and what you need to decide.